Logo image of SREV

SERVICESOURCE INTERNATIONAL (SREV) Stock Fundamental Analysis

NASDAQ:SREV - Nasdaq - US81763U1007 - Common Stock - Currency: USD

1.5  +0.01 (+0.67%)

Fundamental Rating

3

SREV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the IT Services industry. While SREV seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SREV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SREV had positive earnings in the past year.
SREV Yearly Net Income VS EBIT VS OCF VS FCFSREV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA -8.28%
ROE N/A
ROIC -7.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SREV Yearly ROA, ROE, ROICSREV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -5 -10 -15 -20 -25

1.3 Margins

Industry RankSector Rank
OM -4.36%
PM (TTM) -5.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SREV Yearly Profit, Operating, Gross MarginsSREV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SREV is destroying value.
Compared to 1 year ago, SREV has more shares outstanding
SREV has a better debt/assets ratio than last year.
SREV Yearly Shares OutstandingSREV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
SREV Yearly Total Debt VS Total AssetsSREV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

SREV has an Altman-Z score of -0.38. This is a bad value and indicates that SREV is not financially healthy and even has some risk of bankruptcy.
SREV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.38
ROIC/WACC-0.72
WACC9.87%
SREV Yearly LT Debt VS Equity VS FCFSREV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.02 indicates that SREV has no problem at all paying its short term obligations.
A Quick Ratio of 2.02 indicates that SREV has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
SREV Yearly Current Assets VS Current LiabilitesSREV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.02% over the past year.
Measured over the past years, SREV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.97% on average per year.
The Revenue has been growing slightly by 5.31% in the past year.
SREV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.00% yearly.
EPS 1Y (TTM)53.02%
EPS 3Y-12.64%
EPS 5Y-14.97%
EPS Q2Q%150%
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-6.35%
Revenue growth 5Y-5%
Sales Q2Q%8.6%

3.2 Future

Based on estimates for the next years, SREV will show a very strong growth in Earnings Per Share. The EPS will grow by 27.24% on average per year.
SREV is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.09% yearly.
EPS Next Y61.9%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.97%
Revenue Next 2Y-2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SREV Yearly Revenue VS EstimatesSREV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
SREV Yearly EPS VS EstimatesSREV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.00, the valuation of SREV can be described as expensive.
SREV's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.60.
SREV is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 30
Fwd PE N/A
SREV Price Earnings VS Forward Price EarningsSREV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.84
SREV Per share dataSREV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

SREV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SREV's earnings are expected to grow with 27.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y27.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SREV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SERVICESOURCE INTERNATIONAL

NASDAQ:SREV (7/20/2022, 8:16:01 PM)

1.5

+0.01 (+0.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-10 2022-05-10/bmo
Earnings (Next)08-05 2022-08-05/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners6.84%
Ins Owner Change0%
Market Cap150.39M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30
Fwd PE N/A
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB N/A
EV/EBITDA 20.84
EPS(TTM)0.05
EY3.33%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.99
BVpS0.65
TBVpSN/A
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.28%
ROE N/A
ROCE N/A
ROIC -7.14%
ROICexc N/A
ROICexgc -7.64%
OM -4.36%
PM (TTM) -5.14%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z -0.38
F-Score7
WACC9.87%
ROIC/WACC-0.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.02%
EPS 3Y-12.64%
EPS 5Y-14.97%
EPS Q2Q%150%
EPS Next Y61.9%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-6.35%
Revenue growth 5Y-5%
Sales Q2Q%8.6%
Revenue Next Year-0.97%
Revenue Next 2Y-2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A